(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ: ARCT) jumped 5.21% to $28.05 at 10:24 EST on Thursday, after three sequential sessions in a row of losses. NASDAQ is rising 1.4% to $14,540.72, after two consecutive sessions in a row of losses. This seems, so far, an all-around bullish trend exchanging session today.
Arcturus Therapeutics’s last close was $26.66, 78.5% under its 52-week high of $124.00.
Volume
Today’s last reported volume for Arcturus Therapeutics is 47664 which is 92.12% below its average volume of 605288.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 625.3% for the present quarter and 1814.2% for the next. The company’s growth estimates for the ongoing quarter is a negative 72.8% and positive 6.4% for the next.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.
Volatility
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.94%, a negative 1.69%, and a positive 4.25%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 10.79% (last week), 4.69% (last month), and 4.25% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be overbought (>=80).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $28.05 at 10:24 EST, way below its 52-week high of $124.00 and way above its 52-week low of $24.87.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s worth is way under its 50-day moving average of $40.67 and way under its 200-day moving average of $40.29.
More news about Arcturus Therapeutics (ARCT).
